Dacunka M, Sanchez S, Chapoutot L, Marchais A
Pôle vasculaire, service de cardiologie, centre hospitalier de Troyes, 101, avenue Anatole-France, 10000 Troyes, France.
Pôle information médicale évaluation performance (IMEP), centre hospitalier de Troyes, hôpitaux Champagne Sud, 101, avenue Anatole CS 10178, 10003 Troyes cedex, France.
Ann Cardiol Angeiol (Paris). 2019 Nov;68(5):310-315. doi: 10.1016/j.ancard.2019.07.009. Epub 2019 Aug 27.
Heart failure is a public health problem. Since 2013, the National Insurance has been offering the PRADO-IC service for the return home of patients hospitalised for cardiac decompensation. The aim of this study was to assess the impact of PRADO on the rate of re-hospitalisation of patients with heart failure at the centre hospitalier de Troyes (CHT).
This was a 26-month monocentric retrospective study. Patients who were hospitalised for congestive heart failure in the cardiology department of the Troyes Hospital Centre from January 1, 2017 to August 31, 2018, and discharged home with the PRADO-IC service were included in the study. The primary outcome was the assessment of the number of readmissions for heart failure, 6 months before and 6 months after inclusion in the program. Secondary outcomes were the evaluation of the number of all-cause readmissions, the average length of stay and the time to readmission.
The average number of hospitalisations for cardiac decompensation before inclusion in the PRADO decreased from 0.34 to 0.25 (P=0.53) at 6 months. The average number of all-cause hospitalisations before inclusion increased from 0.57 to 0.58 (P=0.50) at 6 months. There was no significant difference in average length of stay and time to re-admission.
We did not highlight the impact of PRADO on the rate of re-hospitalisation of heart failure patients.
心力衰竭是一个公共卫生问题。自2013年以来,国家保险一直在提供PRADO-IC服务,以便因心脏失代偿住院的患者回家。本研究的目的是评估PRADO对特鲁瓦中心医院(CHT)心力衰竭患者再住院率的影响。
这是一项为期26个月的单中心回顾性研究。纳入2017年1月1日至2018年8月31日在特鲁瓦医院中心心脏病科因充血性心力衰竭住院并通过PRADO-IC服务出院回家的患者。主要结局是评估纳入该项目前6个月和纳入后6个月心力衰竭再入院的次数。次要结局是评估全因再入院次数、平均住院时间和再入院时间。
纳入PRADO前心脏失代偿的平均住院次数在6个月时从0.34降至0.25(P=0.53)。纳入前全因住院的平均次数在6个月时从0.57增至0.58(P=0.50)。平均住院时间和再入院时间没有显著差异。
我们未发现PRADO对心力衰竭患者再住院率有影响。